Back to search results

Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Chemotherapy Induced Peripheral Neuropathy (CIPN) · Paresthesia · Numbness · Tingling

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads

  • Bernardino Clavo, MD, PhD

    Study Chair

    Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain

  • Francisco Rodríguez-Esparragón, BSc, PhD

    Study Director

    Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain

  • Jacob Lorenzo-Morales, Prof

    Principal Investigator

    Instituto Universitario de Enfermedades Tropicales y Salud Publica de Canarias - Universidad de La Laguna (IUETSPC-ULL)

  • Francisco Rodríguez-Esparragón, BSc, PhD

    Principal Investigator

    Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain

  • Bernardino Clavo, MD, PhD

    Principal Investigator

    Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain

View source on ClinicalTrials.gov(opens in a new tab)